Europe's largest economy is poised to legalize recreational pot, with ramifications for investors and the thriving segment of illicit sales. Read More
Analyst Articles
COVID's Omicron variant is spooking the markets. Underlying conditions remain bullish, but you need to take protective steps. Read More
The emergence of yet another coronavirus variant is weighing on stocks. But here’s why investors should remain optimistic. Read More
While large Silicon Valley names hog the headlines, this little-known small-cap tech player in the Boston area is poised for outsized growth. Read More
The global emergency over crude oil underscores the rapid ascendancy of electric vehicles as alternatives to petroleum-based transportation. Read More
Conditions seem ripe for a year-end rise in stock prices. As the holiday season kicks into gear, here’s what probably lays ahead. Read More
Strong consumer shopping on the day after Thanksgiving and for the rest of Q4 should provide the stock market with a powerful tailwind. Read More
Merger and acquisition activity has set a torrid pace so far this year, which bodes well for the economy and stock market. Read More
New research shows that psilocybin and other psychedelics ease opioid addiction. It's further evidence that 'shrooms confer health benefits. Read More
Corporate leaders on Q3 earnings calls are increasingly expressing inflation anxieties. Here’s how average investors can protect themselves. Read More